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lysis time they show a very early fibrinolytic capacity (15 mm).
Glomerulonephritides with IgA-IgG mesangial deposits distrib-
ute among groups I and 3, with two different subtypes: as rule to
a higher tissular fibrinolysis corresponds a histopathologic aspect
of a more evident vascular involvement. The other types of GN
showing a not univocal behavior are more difficult to define.
Most of them fall in group 2, which results are difficult to corre-
late. Also the direct correlation between mesangial proliferation
extent and lysis area is worth mentioning, which confirms the
close relations existing between phagocyte activity and glomeru-
lar fibrinolytic activity. The study of tissular fibrinolysis allows
us to obtain useful elements for the evaluation of histopatholog-
ic, immunohistochemical, and laboratory data concomitantly
with the involvement of coagulation as an intermediate damaging
mechanism of primary and secondary GN.
Zinc urinary excretion in patients with relapsing calcium neph-
rolithiasis. M. Surian, G. Graziani, G. Colussi, A. Antonacci, A.
Aroldi, Pd. Giachetti, F. Masi, U. Civati, and L. Minetri. Divi-
sioni di Nefrologia e Biochimica delI'E.O. Niguarda e
deIl'Ospedale Maggiore Policlinico di Milano, Italy. Zinc inhib-
its the precipitation of calcium oxalate and calcium phosphate.
The efficacy of thiazidic compounds in relapsing calcium neph-
rolithiasis (RCN) could also be partly due to an increase in zinc
urinary excretion (ZnE). Plasma Zn, fasting ZnE, and following
oral administration of I g of calcium (Pak's test) were evaluated
in 33 patients with RCN (26 with idiopathic hypercalciuria, of
which 14 were renal (R) and 9 were intestinal (I); 3 primary hy-
perparathyroidism and 4 normocalciuria) and in 17 normal sub-
jects (N). Zn plasma levels in N (85 16 1sg/dl), R (92 15), 1(87
6), and in patients with RCN taken as a group (T) (86.6 12.7)
were not statistically different. Under basal conditions, Zn in N
(0.29 0.21 g!dl GFR) does not differ significantly from R (0.41
0.14), 1(0.36 0.22) and T (0.39 0.16). The calcium load
does not cause significant ZnE changes over basal values neither
in N or R, Land T. But after load, ZnE differs in R(0.45 0.24), 1
(0.39 0.2), and T (0.4 0.22) from N (0.23 0.11), P < 0.005,
< 0.05, and < 0.001, respectively. The ZnEICaE ratio, under
basal conditions, is significantly lower in T (3.43 1.98, P <
0.02) and in R (2.74 0.95, P < 0.005) than in N (7.45 6.2), not
in I. This behavior reflects the different basal calciuria in the
groups examined. ZnE/CaE after load and ZnE/MgE, basal and
after load, are not different in the various groups. In conclusion,
patients with RCN show normal Zn plasma and urinary values.
Three-year experience in the prevention of relapsing calcic neph-
rolithiasis. N. Tessitore, A. D'Angelo, F. Pagano, C. Loschiavo,
A. Fabris, A. Lupo, A. Tasca, P. Morachiello, E. Valvo, G. Pre-
viato, and U. Maschio. Divisione Nefrologia Instituti Os-
pitalieri, Verona, ía C/mica Medica e C/mica Urologica, Univer-
sità di Pat/ova, Italy. During the past 3 years, 230 patients with
relapsing calcic nephrolithiasis (RCN) was studied. Hyper-
calciuria, either absolute (> 350 mg/day) or relative (> 200 mg/
day under a low-calcium diet) and hyperuricuria (> 750 mg/day)
were present in 60% and 34% of cases, respectively. For the pa-
tients with hypercalciuria, a primitive hyperparathyroidism (con-
firmed by surgery) in 8%, intestinal calcium hyperabsorption in
46%, reduced renal calcium absorption in 42%, and phospaturic
tubulopathy in 4% of cases were diagnosed. Two hundred seven
patients were treated with thiazidic (25 to 50 mg/day) and amilo-
ride (2.5 to 5 mg/day). Allopurinol (200 mg/day) was also admin-
istered to 75 of them. During 1,518 years of pretreatment obser-
vation, 922 calculi were expelled (4.4 calculi/patient, 0.6 calculi!
yr). During 349 years of posttreatment observation, 15 calculi
were expelled (0.07 calculi/patient, 0.04 calculi/yr). Differences
are statistically significant. The drug was discontinued out of in-
tolerance in 15 patients (7%). Serial controls during treatment
showed a significant decrease in calciuria, no changes in cal-
cemia and phosphoremia, a slight decrease i kaliemia, and a
moderate increase in uricemia (in patients not treated with allo-
punnol). Thiazidic agents, alone or associated with allopurinol,
proved effective in preventing RCN relapses and changed radi-
cally the prognosis of this syndrome.
Hypertension in dialysis: Usefulness of studying the thyroid
function for the interpretation of the relations between autonomic
nervous system and arterial pressure. A. Zuccalâ, C. Chiarini, E.
Degli Esposti, A. Ligabue, N. Monetti, A. Santoro, A. Sturani,
and P. Zucchel/i. Divisione di Nefrologia Ospedale M. Malpighi,
Bologna, Italy. The recent literature described an increase in
plasma values of catecholamines (CP) in hypothyroid patients. In
our previous reports we had assumed that the presence of a sub-
clinical hypothyroidism, as found in some normotensive uremic
patients, would cause an increase in CP. This secondary increase
could mask the possible correlations between CP levels and AP.
During this study, the following parameters were evaluated in 34
uremic patients under RDT: T3, T4, Revers T3, thyroid-stimulat-
ing hormone (TSH), free T3 (FT3), and T4 fractions (FT4), CPs,
autonomic function test (diving reflex, Valsalva's maneuver, tilt
test). Our data show that a statistically significant reverse rela-
tion does not exist between thyroid hormone and CP levels for
normal or lower borderline thyroid function values. Only when
clear-cut hypothyroidism pictures are present are high CP levels
found also in uremic patients. Disregarding these cases of clear
hypothyroidism, a good correlation is obtained between CP lev-
els and mean AP (r = 0.55; P < 0.01), which confirms the impor-
tance of sympathetic hyperactivity in the genesis of hypertension
in dialysis.
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Plasma renin and dopamine-/3-hydroxylase activities and plasma
aldosterone concentration in toxemic pregnancy. G. Annat, D.
Raudrant, M. Vincent, J. Thou/on, C. A. Bizollon, and J. Sas-
sard. Département de Physiologie, Facultés de Médecine et de
Pharmacie, Service d'Obstétrique de l'Hôpital de Ia Croix-
Rousse, Université Lyon I, Lyon, France. Toxemic and normo-
tensive pregnant women were compared for plasma renin activi-
ty (PRA), aldosterone (PAIdO), and dopammne-/3-hydroxylase
(DBH). At term, hypertensive patients exhibited higher levels of
PRA and PAldo, but similar levels of DBH, progesterone, and es-
tradiol. Their elevated blood pressure was significantly cone-
lated to their levels of PRA. During delivery, levels of PRA in-
creased significantly in toxemic patients in spontaneous labor.
Venous and arterial cord PRA levels were higher in babies born
to hypertensive mothers than in babies born to normoterisive
mothers. Three days postpartum, maternal PRA levels were
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lower than at term. Seven days postpartum, PRA remained high-
er in toxemic than in normal women. Maternal DBH levels did
not change during and after delivery. Plasma DBH activity was
undetectable in cord blood. We conclude that the renin-angioten-
sin-aldosterone system could be involved in the pathogenesis of
toxemia.
Acute renal failure in patients treated with indometacin: Report
of 6 cases. A. Baumelou, A. Agrafiotis, and C. Jacobs. Hópital
de La Pitié, Paris, France. An episode of acute renal failure
(ARF) has been recorded in 6 patients who received indometha-
cm (I), 0.6 to 3 mg/kg of body wt daily. I was prescribed because
of nephrotic syndrome in 3 patients, Dressier's syndrome in 1,
arthrosis in 2. All 6 patients were also treated with diuretics at
first prescription of!. Plasma creatinine (Pcr) was normal before!
in 3 patients, a slight functional impairment of renal function re-
lated to nephrotic syndrome was present in 1, and a moderate
chronic renal failure (Per 168 and 242 mol/liter) existed pre-
viously in 2. ARF supervened within the first 48 hr after start of
I, with overt oliguria in 4 patients. No other side effect possibly
related to the drug was noted. ARF regressed immediately after
discontinuation of!, spontaneously in 3 patients, and after iv.
infusion of albumin in 2. Treatment with peritoneal dialysis was
necessary for 1 patient during 18 days. Histologic examination of
renal tissue performed on the 25th day after onset of ARF yield-
ed diffuse interstitial edema together with a dense infiltration of
mononuclear cells, A persistent moderate decrease of pre-ARF
impairment of renal function has been recorded in this patient. !n
the 5 others, renal function returned to its pre-ARF level, on the
average, 25 days after onset of the complication (range, 5 to 60
days). A reversible worsening of a moderate renal impairment
has been reported in patients with various renal diseases (ne-
phrotic syndrome, lupus, cirrhosis) as a complication of treatment
by nonsteroidal antiinflammatory drugs (NSAID). This is attrib-
uted to the sudden drop of renal perfusion induced by prostaglan-
din-synthetase inhibitors in patients with previous renal hypo-
perfusion in whom the vasodilating effect of prostaglandins is
highly sollicitated to maintain an optimum renal plasma flow.
The clinical data recorded in these 6 patients favor this hypothe-
sis. ARF due to I may occur in patients with a Pcr within a nor-
mal range, but whose renal hemodynamics are impaired because
of hypovolemia, cardiac failure, or intrarenal vascular lesions.
The risk of renal damage is enhanced by the sodium depletion
induced by diuretics. The possibility of ARF secondary to ad-
ministration of NSAID justifies a close monitoring of diuresis
and renal function during the first week of treatment in patients
with a precarious or unstable hemodynamic status.
Comparative study of the coagulation system in primary nephrot-
ic syndrome and renal amyloidosis. H. Ben MaIz, K. Ayed, A.
Kheder, R. Kastalli, F. Kouki and H. Ben Ayed. Service de
Néphrologie (Pr. H. Ben Ayed). Hôpital Charles Nicolle,
Tunis, Tunisia. Thrombosis is generally considered as a compli-
cation of the primary nephrotic syndrome (PNS), particularly in
renal amyloidosis (RA). The aim of the present study was to
compare the coagulation system in 23 cases of RA and 22 cases
of PNS (minimal changes [MC] 3, focal glomerular sclerosis[FGSJ = 2, membranous GN [MGNJ = 4, acute post-
streptococcal GN [APGN] = 4, membranoproliferative GN
[MPGN] = 9). Statistical study was performed by the Mann-
Whitney test. Hypercoagulability state was defined as follows:
platelets> 300,000/mm3, fibrinogen> 7 g/liter, thromboelasto-
gram=r+k>22mm,Emx>73mm,Emx/k>l5,Com-
parative study (PNS vs. RA) showed: (1) significant increase in
platelets (P < 0.03), (2) significant elevation of fibrinogen levels
(P < 0.01), (3) thromboelastogram: (a) significant decrease r + k
(P < 0.01), (b) Emx highly increased (P < 0.001), (c) Emxlk ratio
significantly increased (P < 0.001). To complete this study, we
determined antithrombin !!! level by radial immunodiffusion in
48patientswithNA(RA = ll,MGL = ll,FGS = 6,MGN = 4,
MPGN = 10, APGN = 6) and in 65 presumably healthy adult
blood donors. Statistical analysis shows a significant decrease of
antithrombin III levels in NS compared to controls (C) (C =
24.20 2.36; NS = 19.63 7.52 DS, P < 0.01). This decrease is
greater in NGL and FSG (P < 0.01) than in RA (P < 0.02). In
conclusion, the presence of kinetic and dynamic hyper-
coagulability in RA and SN with MGL and FSG, associated with
frequent decrease of antithrombin !!I level, may explain throm-
bosis tendency. This data suggests therapy with antivitamin K
drug rather than with heparin.
Electrophysiologic study of the neurotoxicity of middle mole-
cules from uremic patients. P. J. Bernard, J. B. Rinaudo, A. Cre-
vat, P. Gallice, N. Fournier, A. Murisasco, and S. Saingra. Lab-
oratoire de Biophysique Cellulaire, Faculté de Médecine Nord;
Laboratoire de Biophysique, Faculté de Pharmacie; Service de
Néphrologie, Hôpital Sainte Marguerite; Marseille, France.
Middle molecules of urine and serum of patients with chronic
renal insufficiency treated by hemodialysis were isolated accord-
ing to Furst's technique. The activity of 7c peak was studied.
The urine of four normal subjects, and serum and urine of seven
patients with chronic renal insufficiency were studied. The activ-
ity of 7c peak was tested on cultured nerve cells (N 115 clones of
mouse neuroblastoma). Electrical activity of these cells was re-
corded with intracellular microelectrodes. Different concentra-
tions of 7c peak were studied on the same cell. Results showed
no neurotoxic action with normal subjects, and five patients'
urine and serum. On the contrary, the serum and urine of 2 pa-
tients had a drastic effect on the electrical activity of the nerve
cells. We observed a decrease of the amplitude of action poten-
tial and its rising phase, a slight membrane depolarization and the
disappearance of the hyperpolarizing post potential. All these
modifications were reversed by washing. These results particu-
larly indicate the complex composition of the 7c peak.
Bicarbonate hemodialysis with a sorbent regenerative dialysis
system: Long-term clinical data. B. Branger, P. Ramperez, H.
Mion and C. Mion. Departement of Nephrology, CHR Nimes;
Laboratory of Biochemistry, CHR Nimes, Nimes, France.
Known side effects of acetate (Ac) buffer during hemodialysis
(HD) prompted us to prepare a simple, efficient, feasible, and
reliable bicarbonate (HCO3) dialysate using a sorbent cartridge
(Redy system). The choice of the Redy system was based on two
important characteristics relative to Ca solubility: (1) Continu-
ous production of CO2 from urea present in the dialysis fluid and
stabilization of the dialysate pH at 7.10 0.15; (2) continuous
addition of Ca to the bath during HD. The Ac-free D41 car-
tridge was used. For initial priming of the system, 1250 ml of 1/6
M sodium HCO3 + 500 ml of normal saline + 3250 of water were
mixed, this solution being recirculated for 30 mm before use to
alkalinize the cartridge; mean electrolyte concentrations were:
pre-HD, HCO3, 53 mri; Cl, 35 mM; Na, 105 mM; post-HD,
HCO3, 46 mM; Cl, 112 mM; Na, 161 msi. The chloride salts of
and K were infused in the bath during HD. Since
January 1977, 480 HD were performed on 20 patients. Bicarbo-
nate HD with the Redy system was used on a long-term basis in 5
chronic HD patients with following results: (1) Excellent intra-
dialytic tolerance (hypotensive episodes, 3.7% HD); (2) better
correction of acidosis, pre-HD (mean sEM) serum HCO3 dur-
ing control period with Ac HD was 17.3 0.9 m, with Redy
HCO3 was 24 0.7 mM;(3) absence of HD induced hypoxemia.
The presence of alumina in the cartridge and the variations of
aluminium (Al) solubility with pH prompted us to study the Al
transfer. Al concentrations in dialysate (mean 5EM) decreased
from 15.1 5.3 rti pre-HD to 4.14 0.9 iM post-HD; 77% of Al
is not ultrafiltrable. Mean plasma Al level of 4 patients was 0.92
/SM pre-HD and 0.44 /LM post-HD with Redy HCO3. The Redy
system offers a simple, efficient and reliable method of bicarbo-
nate dialysis. Long-term tolerance is excellent.
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Time-dependent effect of theophylline administration on water,
electrolyte, and protein excretion in rat. J. Cambar, Ch.
Toussaint, and J. Canellas. Laboratoire de Pharmacodynamie,
Faculté de Pharmacie, Bordeaux, France. The present study
originates from two experimental physiologic and pharmacologic
data: (1) circadian rhythm existence in urinary excretion of wa-
ter, electrolytes, urea, creatinine, and proteins and (2) well-
known theophylline-induced water, electrolyte, and solute ex-
cretion increase. This prompted us to study the time-dependent
effect of xanthic drug administration on the water, sodium, po-
tassium, and protein excretion in the rat. For each experiment,
10 rats living alone in metabolic cages were used: 5 (controls)
received, i.p., I ml NaCI 9% and others 1 ml theophylline (20 mgI
kg). After the single injections (one injection every 6 hours for 24
hours), urine samples were collected during 6 hours (period I, 8
AM to 2 PM; period II, 2 PM to 8 PM; period 11!, 8 PM to 2 AM;
period IV, 2 AM to 8 AM). Foreach urine sample, water volume,
potassium, sodium and protein excretion rates were determined.
Each experiment at each different time point was repeated 5
times. The percent of increase of excretion for the different ex-
perimental groups was as follows: for water, +40, 4% (1), + 123,
7% (II), + 123, 3% (III), +65,4% (IV). For sodium, +39,6% (I),
+223, 2% (Il), + 114, 3% (III), 109,6% (IV). For potassium, + 14,
2% (I), +66, 2% (II), +7, 8% (III), +11, 6% (IV). For proteins,
+43, 6% (I), +37, 0% (II), +19, 6% (III), +23, 9% (IV). From
these results, we can conclude that the diuretic effect of theo-
phylline is significantly modified by the time of drug administra-
tion. Consequently, excretion increases were lowest in period I
and highest in period II. But, if we consider the pharmacologic
definition of a diuretic drug, the most pertinent diuretic effect of
theophylline occurs in period III, with a large water and sodium
excretion increase and with a relatively slight potassium and pro-
tein excretion increase. Such variations could be explained by
circadian variations in glomerular and tubular function intensity,
as demonstrated recently in the rat. In addition, these data con-
firm previous reports concerning the different circadian toxicity
or pharmacologic activity of some diuretic drugs, as furosemide
or chiorothiazide. Moreover, such results open new ways in the-
ophylline chronopharmacology (especially in renal, cardiovascu-
lar, and pulmonary fields), xanthines being known to initiate
myorelaxation of smooth muscle contractile fibers.
In vivo and in vitro response to an acute sodium load in rats with
proliferative glomerulonephritis. P. Cambier, C. Dubois, J. P.
Godon, and P. Mahieu. Institute of Medicine, State University
of Liege, Liege, Belgium. It has been shown that during the au-
tologous phase of nephrotoxic serum nephritis (NTN), the kid-
ney is unable to excrete an acute sodium load. This absence of
natriuretic response is not related to changes in the so-called
"physical factors." Recently, Schreiner et al described an "ac-
celerated" model of NTN characterized by the accumulation of
mononuclear cells in the glomerular tuft. The response to an
acute sodium load in rats presenting such a proliferative glomer-
ulonephritis (ON) has been studied, both "in vivo" and "in vi-
tro" using the isolated perfused kidney technique. The following
data were observed "in vivo" and "in vitro": (a) all the GN rats
presented with severe proteinuria (100 to 400 mg/day), but their
plasma protein concentration was not significantly reduced as
compared to normal rats; (b) the GFR was significantly lower (30
to 50%), contrary to the RPF. After an acute sodium load, the
ON rats did not significantly increase their absolute and relative
sodium excretion "in vivo." After a comparable sodium load,
the isolated perfused GN rat kidneys increased their fractional
sodium excretion in the same proportion as normal kidneys (+ 9
5.6% for GN rat kidneys and + 10.7 2.6% for normal rat
kidneys, expressed in mean differences from initial values). The
absolute sodium excretion of the GN rats, however, was lower
(+3.3 1.6 vs. +7.5 1 sEq/min/g), as well as the filtered so-
dium load (32.3 4.2 vs. 75.9 8.2Eq/minIg). The data dem-
onstrate that, in this model of proliferative ON, the ability of the
kidney to increase its sodium excretion is not completely abol-
ished.
A case of familial Bartter's syndrome. P. L. Caraman, J. M.
Rouillard, R. G. Demicheli, M. Kessler, C. Huriet, A. Mimran
Service de Medecine Interne A, Hôpital Bon-Secours, CHR
Metz-Thionville; Service de Nephrologie, CHU Nancy-Brabois;
Service de Médecine C, CHR NImes, France. Bartter's syn-
drome was diagnosed in a young 23-year-old patient by the for-
tuitous discovery of hypokalemia. We show that the regulation
mechanisms of the renin-angiotensin-aldosterone system were
normal, especially by the saralasin and phenoxybenzamine tests.
The urinary kallikrein excretion was found to be normal, and an
increase of the urinary prostaglandins with inversed PGE2/PGF2.
was noted. The chloride balance was persistently negative, sug-
gesting a defect in active chloride tubular reabsorption. No
serum anomaly was found in the parents, but Bartter's syndrome
was discovered in a 17-year-old brother in whom severe scoliosis
appeared during spontaneous catchup growth, correcting a
growth deficit which had persisted to prepuberty. Familial pso-
riasis was also noted, presented by the mother, a sister, and the
first affected brother. The affected brothers are HLA-different.
Treatment by indomethacin, which lowered the hyper-
prostaglandinism, incompletely corrected the laboratory abnor-
malities.
Aglomerular pathways in intrarenal microvasculature of aged
rats. Daniel Case/las and Albert Mimran. Dept. Medicine D,
CHR Saint-Charles, Montpellier, France. The existence of vas-
cular connections between afferent and efferent arterioles of re-
nal glomeruli is still controversial. Since this vascular arrange-
ment, if present in numerous glomeruli and associated with other
forms of aglomerular pathways, might be of important functional
significance, we reinvestigated this topic in aged male Sprague-
Dawley rats. By means of silicone rubber injections and stereo-
scopic observation of cleared kidney slices, we confirmed the
existence of several types of aglomerular arterial pathways. In
the superficial cortex, some interlobular arteries divide to form
aglomerular banches (Ludwig's arterioles) towards cortex cor-
ticis. In the juxtamedullary (JM) cortex, these pathways are rela-
tively more numerous, comprising; (a) vasa recta vera, (b)
glomeruli whose afferent and efferent arterioles form a continu-
ous vessel, and (c) glomeruli with two efferent arterioles, one
bypassing the glomerular tuft. Vascular structures of type b and
c were estimated to be present in 5% of JM glomeruli with ef-
ferent vascular casts (casts present in 52% of JM glomeruli). No
diameter measurements were made since rubber casts often re-
tracted from the surrounding vessel, but in all instances shunts
had a larger diameter than glomerular capillary anastomoses.
One already proposed hypothesis was that structures a, b, and c
represent different steps of a degenerative process in the aged
rat; however, glomeruli of type b might have resulted from in-
complete filling of type c with silicone rubber. With regard to the
physiologic significance of these vascular structures (types a, b,
and c), results obtained in the rat by the microsphere technique
are in agreement with our morphologic observations since only
5% of spheres trapped in the juxtamedullary cortex were found
beyond the glomeruli of aged rat kidneys.
Arterial hypertension and arteriovenous fistula: Echo-
cardiographic studies. D. Chevet, J. P. Herve, P. Lepogamp, L.
Revillon, and J. M. Scholl. Service Maladies infectieuses, Unite
de Nephrologie Hópital Pontchaillou Service Cardiologie B,
Hótel-Dieu, Rennes, France. A child was afflicted with Henoch-
Schönlein purpura at the age of 6 years. After 4 years of support-
ive hemodialysis, worsening of chronic arterial hypertension
caused episodes of heart failure. The hypertension did not re-
spond to bilateral nephrectomy or to volume depletion (—6.8%
body wt). The hypertension was only controlled with surgical
banding of the humeral arteriovenous fIstula (HAVF). A TM
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mode echocardiographic study was performed prior to and fol-
lowing surgical banding of the HAVF. Following banding: (1)
arterial hypertension became controlable by volume depletion
during dialysis session (—2.5% body wt); (2) The cardiac index
decreased from 6.5 to 3.6 liters/mm; (3) The HAVF flow de-
creased from 1450 to 650 mI/mm; (4) Left ventricular function
parameters (ejection fraction, shortening radion, mean velocity
of fiber shortening) were changed by dialysis session even
though they were unchanged following surgical banding. This ob-
servation, unique in our experience, is a quantitative demonstra-
tion of the influence of abnormally high HAVF flow in the etiol-
ogy of arterial hypertension and heart failure (in renal patients).
Labetalol in the treatment of hypertension of pregnancy: Clini-
cal effects and interactions with plasma renin and dopamine beta-
hydroxylase activities, and with plasma concentrations of cate-
cholamine. B. Coevoet, J. Leuliet, E. Coinoy, J. F. de Frémont,
J. M. Hardin, J. D. Gherbrani, J. C. Boulanger, and A. Four-
flier. CHU Amiens, Institut Gustave Roussy F Villejujf France.
Labetalol is a betablocker with alpha receptor blocking property.
Since this latter may counteract the increase in uterus con-
tractility induced by betablockade, it seemed to us warranted to
use it in the treatment of gravidic hypertension. Fifteen hyper-
tensive pregnant women (BP> 135 to 85 mm Hg at two measures
after rest) were treated (2 toxemias, 3 permanent hypertensions,
and 10 isolated hypertensions). Under a mean daily dose of 800
mg of labetalol, BP decreased from a mean of 156 to 94, to 127 to
80mm Hg in supine position and from 153 to 94, to 126 to 81 mm
Hg in standing position. In 2 cases, high BP was not controlled (1
toxemia, 2 permanent hypertensions). No side effect occurred
requiring treatment discontinuation. Obstetrical results were sat-
isfactory: Delivery was premature in only 2 cases: one spontane-
ously at 6 months, the other by cesarian section at 8 months. In
all cases, APGAR scores were above 9 at 5 mm. Plasma concen-
tration of adrenaline and noradrenaline, and plasma renin and
dopamine betahydroxylase activities were measured before and
after I month of treatment: they did not show any consistent
change during treatment. In conclusion: (1) labetalol is efficient
and well tolerated in the treatment of gravidic hypertension, (2)
its efficiency is not correlated with the variations of plasma levels
of norepinephrine and epinephrine, nor with the variations of
plasma renin and dopamine betahydroxylase activities.
Stability of blood pressure and vascular resistance during high-
flux hemofiltration compared to hemodialysis. G. Deschodt, M. C.
Beau, G. Claret, H. Mion, C. Mion, and S. Shaldon. Dept. of
Nephrology and Biochemistry, University Hospital NimesI
Montpellier, and AIDER, Montpellier, France. Symptomatic
hypotension (SH) is reported as less frequent during hemo-
filtration (HF) than it is during hemodialysis (HD). Using a high-
flux postdilutional HF system in 5 patients, the % change in cal-
culated total vascular resistance (VR) (derived from noninvasive
indocyanine green cardiac output, Arteriosonde blood pressure
(MAP), and ECG pulse) was compared during 4 hr HF and 4 hr
HD with similar urea clearances (HD: 140 4 mI/mm; HF: 137
5 mI/mm). The two liquids, reinjection (HF), and dialysate (HD),
were of identical composition containing: acetate 45 mmoles/liter
and sodium 140 mmoles/liter. Changes in arterial 02 tension
(PAO2), intratreatment weight loss (BW), % hematocrit in-
crease (Hct), drop in serum osmolality (Osm), and urea (urea)
were also measured. The results showing maximal changes
(mean SD) were:
Despite similarity in weight loss, hypovolaemia, hypoxemia, and
changes in osmolality and urea and an equivalent maximal in-
crease in serum acetate (HD: 5 mmoles/liter; HF: 4.9 mmoles/
liter) decrease in MAP was less with HF and was associated with
a rise in vascular resistance in the last 2 hours, whereas in HD
the resistance decreased progressively. Similar changes in VR
were seen when bicarbonate replaced acetate. While SH is multi-
factorial in origin, the difference between the two treatments, not
explained by current hypotheses of less Osm, volume shifts, or
direct effect of acetate on yR. The possibility that a large molec-
ular-weight inhibitor of sympathetic activity is efficiently re-
moved by HF and not by HD remains to be proven.
Evidence for an acute phase of the lupus disease in 2-month-old
NXB x NZW mice. G. J. Fournié, M. Gayral-Ta Minh, S. Haas,
J. P. Pourrat, and J. J. Conté, Laboratoire d'Immunopathologie
Rénale. Service de Néphrologie et d'Hémodialyse. CHU
Toulouse-Purpan, Toulouse, France. The spontaneous develop-
ment of antiacid deoxyribonucleic (DNA) antibodies and the
appearance of circulating immune complexes in NZB x NZW Fl
hybrids mice are still poorly understood. Since both phenomena
might be related to the unknown etiologic factors involved in
the development of murine lupus, the time of appearance of Clq
binding substances and anti-DNA antibodies has been studied in
young NZB x NZW female mice. Two kinds of results ob-
tained in two independently studied groups of mice indicate
that there is an acute phase of the disease during the second
month of life: first, the occurrence of Clq binding substances
and the appearance of high levels of antisingle-stranded DNA
antibodies in blood are simultaneous. Both phenomena are
followed by a significant and concomitant decrease of levels of
Clq- and DNA-binding substances. Second, there is a correla-
tion between the level of Clq-binding substances at the 9th week
of age and an increase in levels of anti-DNA antibodies be-
tween the 7th and the 9th week of age. These findings suggest
that in NZB x NZW mice a common mechanism is implicated in
the appearance of Clq binding substances and in the induction of
anti-DNA antibodies. Both events might be related to some still
unknown etiologic factor(s) implicated in the triggering of the
lupus disease.
Prevention of hemodialysis-induced hypoxemia by use of bi-
carbonate-containing dialysate. G. Fournier and N. K. Man,
Centre Hospitalier de Chartres and Département de
Néphrologie, Hôpital Necker, Paris. The symptoms and signs of
cardiovascular dysfunction observed in some patients during he-
modialysis are attributed to arterial hypoxemia and inadequate
correction of metabolic acidosis with acetate-containing dialy-
sate (AC). To investigate the possibility that acetate per se might
be responsible for dialysis hypoxemia and dialysis side-effects,
we compared the effect of 35-mM acetate-containing dialysate (N
= 15) vs. 35-mM bicarbonate-containing dialysate (BC) (N = 9)
on arterial P02 (Pa02) in 18 patients during a 4-hr dialysis with
closed batch dialysate delivery system and PAN dialyzer. Arteri-
al blood samples for Po2, Pco2 and [HCO3-] were obtained be-
fore and after dialysis. HCO3- mass transfer was calculated from
the determination of [HCO3-] in dialysate at the end of the dial-
ysis session. Ultrafiltration flow rate of 12.5 mI/mm on average
was maintained constant during the whole procedure. There
were no significant changes in pre- and post-dialysis Pao2 (94.8
3.5 and 93.7 5.8mm Hg) and Paco2 (32.6 1.1 and 33.9 0.9













HD 16 6 2.4 0.3 23 8 20 4 21 4
—25 10 —32 8
HF 20±7 2.3±0.4 25 10 19±3 19±4 +50± 15 — 5±2
P NS NS NS NS NS <0.01 <0.01
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creased significantly (P < 0.05) from 101.1 2.2 and 34.4 1.0
to 93.7 3.1 and 31.8 0.9 mm Hg, respectively during AC
dialysis. Metabolic acidosis was corrected more optimally during
BC dialysis (pre-[HCO3-]: 18.9 0.8 rnmoles/liter and post-
[HC03]: 26.8 0.9) than during AC dialysis (pre-[HC03]: 19.9
0.6 mmoles/liter and post-[HC03]: 22.3 0.5 mmoles/liter)
with less fixed base consumption per dialysis session (238.2 vs.
455.3 mti). Hypotension episodes, muscle cramps, headache,
vomiting, and fatigue, which occurred frequently during AC dial-
ysis, were minimal during BC dialysis. Dialysis hypoxemia dur-
ing AC dialysis may be related to an effect of acetate load on
cardiovascular function, an increased O consumption for ace-
tate metabolization and a greater CO2 removal, which in turn
could induce hypoventilation. These data provide support for the
beneficial effects of bicarbonate-containing dialysate, especially
in patients with impaired cardiovascular function.
Is hemofiltration a suitable method to treat terminal uremia at
home? J. F. de Frémont, B. Coevoet, G. Lambrey, J. M. Hardin,
P. Morinière, A. Fournier, CHU Amiens, France. Home treat-
ment of terminal uremia must be well-tolerated and easily and
safely performed. To assess to what extent hemofiltration (HF)
may be superior to hemodialysis (HD) in this regard, we com-
pared the tolerance and the technical aspects of 508 hemodialysis
(HD) procedures at home during 2 to 26 months in four patients
versus those of 496 hemofiltration (HF) procedures performed at
home for 2 to 22 months in 4 other patients. The clinical toler-
ance is better in HF because the frequency of hypotension (1% in
HF vs. 12% in HD) and cramps (1% in HF vs. 5% in HD) is lower
than in HD. The technical suitability for home was assessed on
three parameters: the length of machine preparation, the dura-
tion of training before attaining autonomy, and the incidence of
technical failures requiring the visit of a technician. HF appears
to be technically advantageous because (1) this method does not
need water treatment, (2) the machine preparation is shorter in
HF (40 5 mm) than in HD (70 20 mm), (3) the length of
training is also shorter in HF (2 months) than in HD (4 months),
(4) the technical failures are less frequent (2% of the HD proce-
dures and 0% of the HF procedures). In conclusion, HF appears
to be better adapted than HD to home treatment of terminal ure-
mia.
Significant role of aluminum hydroxide gels in increasing serum
aluminum levels in hemodialysis patients: A case of dialysis enceph-
alopathy syndrome. A. Gross, H. Maheut, E. Prenat, J. P. Riv-
ory, J. Rivail, and M. Weber. Néphrologie clinique et
experiment ale, Faculté B de Médecine, Nancy, France. In an
iterative hemodialysis center, although the currently used water
and dialysis fluid were free from aluminum, a typical case of pro-
gressive encephalopathy was observed in a Al(OH)3 gel-treated
patient. After the medication was stopped, his hyperaluminemia
decreased and neurologic features progressively disappeared. The
observation led to a determination of the serum aluminum levels
in all patients treated in the same center. In those who had taken
no aluminum hydroxide gels, values were always lower than the
normal upper limit. On the other hand, among those who were
taking this medication, some had high levels. These patients
were receiving two types of aluminum-hydroxyde gel, having dif-
ferent concentrations of aluminum. The serum aluminum mean
concentration was significantly higher in the group treated with
the Al(OH)3 gel, which contained the higher amount of alumi-
num.
Pharmacology of water transport: Effects of the aminoglycoside
amikacin. A. Grosso, J. Fabre, and R. C. de Sousa.
Département de physiologie et Policlinique de médecine,
Département de médecine, University of Geneva, Switzerland.
Use of suitable models and techniques for the study in vitro of
water transport revealed that transepithelial osmosis is sensitive
to a number of drugs commonly used in clinical practice. We
report here work done with amikacin. Three main reasons led us
to the consideration of this antibiotic: (1) reports on episodes of
polyuria during the administration of aminoglycosides; (2) exis-
tence of Ca-dependent steps in the vasopressin-induced stimula-
tion of water flow; (3) interaction between aminoglycosides and
calcium in several biological systems. Quarter-bladders of toads
Bufo marinus were mounted as diaphragms in glass chambers
and water flows were monitored with an automatic, volumetric
technique. Following incubation for 2 hours with amikacin (1
mM) added to the serosal medium, both amikacin-exposed and
control quarter-bladders were challenged with either vasopressin
(50 mU/mi) or cyclic AMP (5 mri). The aminoglycoside reduced
the response to both agents by 40% (P < 0.001, N = 15) and 65%(P> 0.001, N = 6), respectively. In contrast, when serosal hy-
pertonicity (NaCI, 100 mM) was used as the hydrosmotic stimu-
lus, there was no significant difference between control and ex-
perimental tissues (N = 11). This action of amikacin on trans.
epithelial osmosis mimics the effects previously reported with
colchicine. Furthermore, according to current views on water
transport, the combination of an inhibition of the vasopressin
and its messenger, cyclic AMP, with a normal response to sero-
sal hypertonicity, suggests that amikacin affects a Ca-dependent
step beyond the generation of cyclic AMP.
Bilateral renal malakoplakia: One case and a review of the liter.
ature. D. Hi/lion, C. Felsenheld, A. Bergue, and J. P. Fend/er.
CHI Poissy, France. Mrs. M., aged 81 years, was referred be-
cause of right loin pain, a severe infectious syndrome, aseptic
pyuria, and a creatinine of 15 mg/liter. There was a long past
history of E. co/i urinary tract infections. IVP revealed upward
displacement of the lower branches of the right calyx, while arte-
riography revealed devascularized areas throughout the cortex
of the right kidney (12.5 x 7 cm). The vascularization of the me-
dulla was not normal, there was neither a collateral circulation
nor neovascularization. The left kidney (13 x 7 cm) was normal.
The diagnosis was that of neoplastic infiltration or abcess of the
kidney. The patient died suddenly. At autopsy, both kidneys
(RK, 220 g, LK, 180 g) were deformed by yellowish masses,
which on section proved to be firm nodules of variable size with a
distinct border and sometimes surrounded by a narrow hemor-
rhagic band, necrosed at the lower pole of the right kidney. The
pyelocalyceal cavities and ureters were free of disease. Histolog-
ic examination revealed granulomatous inflammatory infiltrates
with the presence of Von Hansemann cells and Michaelis Gut-
mann bodies. About 30 cases of renal malakoplakia have been
reported. A past history of urinary tract infections due to gram-
negative organisms is a constant feature. Women are affected in
80% of cases. Apart from the appearance of a febrile tumour, the
clinical features are those of chronic pyelonephritis, with or
without renal failure, hypertension, obstructive anuria, or septi-
caemia. IVP and arteriography are normal or reveal a large kid-
ney with displaced cavities, and devascularized areas with pe-
ripheral neovascularization, sometimes extending beyond the
renal area. The diagnosis is often made in nephrectomy speci-
men, and very rarely by needle biopsy or frozen section. Macro-
scopically, the appearance is either of plaques opening into the
excretory system, or of confluent intraparenchymatous nodules
modified by necrosis, hemorrhage and suppuration. Mortality is
high despite antibiotic therapy. Although malakoplakia is defined
only histologically, the similarity between the cases reported is
such that it is felt that the diagnosis may be suggested on the
basis of clinical and radiological arguments and that frozen sec-
tion examination may avoid nephrectomy.
HLA phenotype in Berger's disease. A Houssin, J. D. Bignon,
J. P. Soulillou, J. Guimbretiere, and J. Guenel. Laboratoire de
Typage Cellulaire, Centre de Transfusion Sanguine Nantes;
Service de Nephrologie, Hôpital St. Jacques, U.E.R. de
Médecine, CHU Nantes; and Service de Néphrologie du CHU
dAngers, France. Contradictory results have been published de-
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scribing a possible linkage between Berger's disease and certain
HLA phenotypes such as HLA-BW35 and HLA-Bl2, while oth-
er authors did not observe any such association. We report here
our own results obtained from the typing of 73 patients with Ber-
ger's disease defined on clinical (noncirrhotic) and immuno-
histologic criteria. No antigen either from the HLA-A locus or
the HLA-B locus is significantly more frequent when the patients
are compared to 181 normal subjects typed in the same laborato-
ry during a similar period. Antigen-by-antigen analysis gives, re-
spectively x2 at 1.36 for HLA-B12 and 0.12 for HLA-Bw35, the
antigens which had been incriminated. We also note a nearly sig-
nificant increase (respectively, x2 at 3.8 and 3.84) of lacking anti-
gens at A and B loci in Berger's population.
Natriuresis induced by head-out water immersion in normal
subjects and in one patient with diabetes insipidus. H. A. Jahn and
G. M. Rocha. Univ. Louis Pasteur, Strasbourg, France.The pur-
pose of this study was to elucidate the nature of diuresis after
increase of central blood volume during head-out water immer-
sion (WI). Seven normal subjects (N) and one patient with diabe-
tes (D) were left for 2 hours in a 37° C corporal bath. Urine was
collected during a period of 2 hours, before, during, and alter the
bath. We calculated creatinine clearance, osmolar clearance
(Com) and free water clearance (CHo). Na, Cl, K, and urea were




V,ml/min 0.7 0.13 3.9 0.9 1.5 0.3
Cosm,ml/min 1.6 0.3 3.3 0.6 2.6 0.6
CHO
D(N= 6) —0.9 0.2 +0.8 0.7 —1.0 0.4
V,ml/min 5.0 0.6 5.0 0.4 4.2 0.5
Cosm,ml/min 1.9 0.4 2.3 0.4 1.6 0.3C0 3.1 0.7 2.8 0.6 2.5 0.6
During the bath in N, diuresis was increased by 457%, Co,m in-
creased by 106%, and CH by 188%. During the bath, the urinary
flow remained unchangeJ in D, Cosm increased by 21%, and C0
decreased slightly. The Cosm increase was mainly due to an in-
creased natriuresis in both N and D.
Before During After
Na, mmoleslmin
N 0.09 0.01 0.25 0.04 0.20 0.01
D 0.09 0.02 0.17 0.03 0.11 0.01
The creatinine clearance changes can not be interpreted as a ma-
jor determinant factor of natriuresis. Natriuretic humoral fac-
tor(s) in both N and D can be suspected as shown by urine injec-
tion in a rat test. The increase of CH0 in N and the absence of an
increase in D show that the increase of the urinary flow in N is
related to an inhibition of antidiuretic hormone.
Long-term evolution of diffuse proliferative lupus nephritis: Ret-
rospective study of 32 patients treated with corticosteroids or com-
bined corticosteroids and cyclophosphamide. P. Jungers, M.
Dougados, F. Tron, J. Leibowitch, P. Lesavre, D. Droz, andJ.
F. Bach, Department of Nephrology and INSERM U 25,
Necker Hospital, Paris, France. Thirty-two patients (28 females,
4 males) with systemic lupus erythematosus (SLE) and initial
kidney biopsy showing diffuse proliferative glomerulonephritis
were observed between January, 1962, and June, 1979. Non-
randomized treatment was either with corticosteroids (CS) alone
(14 pts, group I) or combined CS + cyclophosphamide (CY) (18
pts, group II). In the latter group, CY was started together with
CS in 8 pts, some months or years later in 10, because of resis-
tance (5 pts) or intolerance (5 pts) to CS. Renal insufficiency was
initially present in 5/14 of group land 8/18 of group II; with major
systemic manifestations of SLE, in 6/14 and 8/18, respectively.
Mean (± sEM) daily dose of CS for the first 3 months was higher
in group 1(1.14 0.10 mg/kg) than in group 11(0.88 0.10, P <
0.01). However, the cumulative dose of CS was not different
(23,400 6,600 vs. 21,500 3,600 mg). Mean duration of CY
was 8.5 1.4 months (cumulative dose: 24,500 3,400 mg). No
significant difference was found when comparing the two actuari-
al survival curves by the log-Rank test. Five pts died (2 in group
I, 3 in group II). Four pts (2 in each group) are treated by mainte-
nance dialysis. The other 23 pts are alive, with a mean followup
duration of 47 10 months. The proportion of patients with nor-
mal renal function and quiescent SLE is the same in the two
groups (10/14 vs. 13/18). Major renal and/or extrarenal flare-ups
of SLE were also observed in the same proportions (5/14 vs.
5/18). In conclusion, when comparing patients having received
CS alone, or initially associated with CY, no significative advan-
tage appears for combined treatment against CS alone. How-
ever, secondary association of CY to CS may be indicated when
CS are ineffective or poorly tolerated, and often restores similar
overall results as elective CS treatment.
Adverse effect of vitamin D metabolites on osteitis fibrosa in pa-
tients on chronic hemodialysis: Critical role of Induced hyper-
phosphatemia. G. Lambrey, J. F. De Frémont, B. Coevoet, J. L.
Sebert, R. Makdassi, J. Guéris, P. Marie, P. Meunier, and A.
Fournier. CHU Amiens, Hôpital Lariboisière, Paris, Université
Claude Bernard Lyon, France. An association of 1-alpha-OH-
vitamin D3 and 25-OH-vitamin D3 was given to 18 adults on
chronic hemodialysis for 12 months. Initial daily doses were re-
spectively I and 50 g, but in 17 patients, to correct hyper-
calcemia, the treatment was repeatedly discontinued and then
resumed at half doses. The patients, already on dialysis for 32
months, were dialyzed 3 times 4 hours a week against a dialysate
calcium of 7.0 mgldl and were taking an oral calcium supplement
of 1.2 g and variable doses of Al(OH)3. Skeletal X-rays and histo-
morphometric evaluation of iliac bone biopsy specimens were
performed before and 6 and 12 months after vitamin D treatment.
Before treatment no patient had osteomalacia, but 13 had in-
creased active resorption surface without marked radiologic ab-
normalities. At the end of the study, no change was observed in 7
patients, but bone resorption increased in 6 and decreased in 6
others. Histologic worsening of hyperparathyroidism was associ-
ated with an increase in plasma concentrations of phosphate (P
< 0.05) and parathyroid hormone (P < 0.01) in spite of higher
"prescribed" doses of Al(OH)3 and similar changes in plasma
concentrations of 25-OH-D. It is concluded that: (1) basic treat-
ment of dialysis osteodystrophy adequately prevents osteo-
malacia but not hyperparathyroidism, (2) addition of vitamin D
metabolites to this treatment may be either beneficial or noxious
according to whether the induced hyperphosphatemia is or is not
adequately prevented. Therefore, this addition seems to us war-
ranted, in adults, only when bone diseases give X-ray abnormal-
ities and/or increased serum alkaline phosphatase.
Postpartum nephrosclerosis. A. Larcan, H. Lambert, M. C.
Laprevote-Heully, J. Y. Hesse, A. Gerbaux, and M. Grignon.
Service de Reanimation, Centre Hospitalier Universitaire, Nan-
cy, France. The authors report an observation of acute renal in-
sufficiency occurring 7 weeks alter normal delivery in a 28-year-
old primiparous woman under estroprogestogens for 3 weeks.
The clinical picture associated anuna with severe hypochromic
anemia and severe left ventricular failure in the absence of high
blood pressure. There was no sign of hemolysis or consumption
coagulopathy. Immunologic investigations were normal. The
course, with treatment by hemodialysis and heparin, was charac-
terized by the persistence of anuria and by the aggravation of
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cardiac insufficiency leading to death 10 weeks after delivery.
The renal histologic lesions, studied on an early biopsy and post-
mortem biopsies, associated diffuse endocapillary proliferating
glomerulonephritis with ischemic tubular and vascular changes.
The vascular intima was fibroedematous with occasional intra-
vascular thrombi. Fibrinoid necrosis of arcuate and intralobular
artery walls and of glomerular afferent arterioles was found. In
the liver there was a centrolobular necrosis with congestion of
sinusoid capillaries. The myocardial tissue was normal. This ob-
servation can be classified among postpartum nephroangioscle-
rosis; about 30 cases have been reported in the literature. The
vascular lesions observed exclusively in the kidney are similar to
those observed occasionally during estro-progestative treatment.
The clinical symptoms and the histopathological changes are
close but not similar to those observed in the hemolytic and ure-
mic syndrome of the postpartum period, in which fibrin arteriolar
and capillary thrombi are found.
Vascular-renal diseases in pregnancy: Study of 75 cases in wom-
en without previous kidney disease or hypertension. M. Olmer, J.
Gugliotta, C. Ebrayat, M. Gamerre, M. Grandvuillemin, and H.
Ruf. Service de Néphrologie, Clinique Obstétricale, Hôpital de
Ia Conception, Marseille, and Materniré de la BelIe-de-Mai,
Marseille, France. In 75 pregnant women, vascular renal disease
was observed. Of them, 33 were nulliparas. In 35 cases, the fetus
was dead with early spontaneous abortion or premature delivery
of a dead fetus. Most patients had glucose and lipid metabolism
abnormalities. High blood pressure persisted after delivery in 16
women. On renal biopsy, light microscopy was normal in only 7
cases, but in 56 kidney biopsies a more or less severe "glomeru-
lar capillary endotheliosis" was present in association with arte-
riolar lesions in 50 cases. C3 deposits in the arteriolar walls were
frequent as well as glomerular and mesangial 1gM and IgA depos-
its. Some of these vascular changes were probably present be-
fore pregnancy.
Reduction of treatment time with high-flux postdilutional hemo-
filtration. P. Rampérez, M. C. Beau, G. Deschodt, C. Mion, and
S. Shaldon, Dept. of Nephrology, CHRU Nimes and
AIDER Montpellier, France. The observation of improved
vascular stability during HF prompted this study in 2 anuric
ESRD patients on hemodialysis (HD) for 2 and 4 years, respec-
tively, selected because of regular availability of Q' 500 ml/min.
Using two Amicon polysulphone 0.55 m2 or two Gambro poly-
amide 0.65 m2 capillary hemofilters in series, mean plasma water
filtration rates (QUF) of 150 5 mI/mm (whole blood urea clear-
ance 162 6 mI/mm) WBUC) were obtained in patient 1 (body wt,
100 kg) during 6 months (3x/week). Patient 2 (body wt, 65 kg)
produced QUF 172 10 mI/mm (WBUC 185 12 mI/mm) over 9
months (3x/week). Patient 1 required 31.5 liters 3x/week, of ul-
trafiltrate for pretreatment BUN of 100 5 mg/dl, and creatinine
of 16 1.3 mg/dl. Patient 2 required 25 liters 3 xlweek for similar
pretreatment values. On HD, both patients required 5 hr, 3 </
week, (QD 500, 1 m2 Gambro Lundia dialyzer) due to fluid remov-
al intolerance. However, BUN values were 10% lower than with
HF, but creatinine levels were similar. With HF, treatment time
was shortened to 31/2 hr in patient 1 (weight loss, 3.5 0.9 kg)
and 2 hr 20 mm in patient 2 (weight loss, 2.9 0.4 kg). During
200 HF treatments (150 with acetate and 50 with bicarbonate re-
placement fluid), no fluid intervention was required and maximal
blood pressure drop (LMAP) was < 10% with marked reduction
in post treatment fatigue and stable hematocrit (22 and 24%)
without blood transfusions. With HD, /4 dialyses required fluid
intervention and LMAP was always> 20% for same weight loss
as in HF. High flux HF offers a shortening of treatment time with
fewer staff due to improved fluid removal tolerance. The limiting
factor is in the requirement of blood flow of 500 mI/mm. If these
preliminary results are confirmed, high flux HF could become
the treatment of choice for patients with vascular unstability in
whom HD is contraindicated; in addition the shortening of treat-
ment time should result in a significant economic benefit.
Cardiac changes in chronic renal failure: Echocardiographic
studies. L. Revillon, J. M. Scholl, C. Almange, D. Chevet, andJ.
P. Herve. Service Cardiologie B, Hótel-Dieu, Service maladies
infectieuses, Unite de Nephrologie Hôpital Pontchaillou,
Rennes, France. Twenty-four patients were investigated using
TM mode echocardiography preceding and following dialysis
session prior to and during occlusion of their arteriovenous fis-
tula (AVF). (A) Those patients with arterial hypertension had
significant increases in both septal thickness and left ventricular
mass (P <0.001). (B) Occlusion of the AVF caused a significant
reduction in cardiac output (P <0.001) secondary to significant
diminution of end-diastolic diameter and heart rate (P < 0.01).
Peripheral resistance rose significantly (P < 0.01) in conjunction
with arterial pressure. Left ventricular function parameters de-
creased significantly (P <0.001). Individual variations remained
small and did not approach pathologic values. Flow through the
AVF (QF) was calculated from the difference in cardiac output
before and after occlusion. QF varied from 300 to 2000 mllmin.
(C) Hemodialysis session caused a drop in cardiac output (P <
0.001) following the reduction in end-diastolic diameter and in-
crease in heart rate. This change in cardiac output was correlated
with the loss of weight of the patient (regression coefficient,
0.84). Other parameters did not change. Echocardiography al-
lowed measurement of a parameter proportional to AVF flow as
well as an appreciation of cardiac performance. With a single
exception, the hemodynamic effects of the AVF were minor. The
volume loss due to the artificial kidney was the major cause of
changes in cardiac output. Anemia caused only moderate
changes provided that hemglobin was kept at 7 g/dl or higher.
The echocardiographic findings are more typical of patients with
essential hypertension than those with myocardiopathy.
Muscular work capacity and oxygen transport in chronic hemo-
dialysis patients. P. Rocha, G. Dongradi, B. Baron, F. Blanchet,
D. Duruy, J. C. Kahn, and J. P. Fend/er, CHI, Poissy,
France. Limiting factors in muscular work capacity and maxi-
mum oxygen consumption (V 02 max) were studied in 7 male
chronic hemodialysis patients. During maximum exercise, the
load (60 or 90 W) and V 02 max (mean = 1190 mI/mm) were far
lower than the maximum load and V 02 max of normal subjects.
In comparison with normal subjects, the decrease in muscular
work capacity: (1) Was not related to a decrease in cardiac per-
formance; maximum cardiac output (max CO) (19.0 1/mm) was
not lower than the normal max CO; (2) was not related to any
appreciable fall in pulmonary oxygen transfer; the partial pres-
sure of oxygen in arterial blood (Pa02) was no lower than normal
and was no lower during maximum exercise (86 mm Hg) than at
rest in a lying position (85 mm Hg); (3) was not related in the
absence of pulmonary edema, to water and salt overload; after
hemodialysis and a fall in cardiac cavity filling pressures max
CO, V 02 max and Pa02 were the same as before dialysis; (4) was
closely related to anemia; on the one hand patients having ac-
complished the maximum exercise of 60 W had on average a
lower hemoglobin level than the patients accomplishing the max-
imum exercise of 90 W, and on the other hand, the two lowest
hemoglobin levels corresponded to the two lowest V 02 max, and
the two highest hemoglobin levels corresponded to the two high-
est V 02 max; (5) was apparently linked to the arteriovenous fis-
tula (AVF); for a given max CO, a priori, the AVF was respon-
sible for a fall in V 02 max proportional to the flow rate in the
AVF, this fall being marked when the AVF flow was high; (6)
was not improved by a decrease in the aThnity of hemoglobin for
oxygen; shift on the right of the hemoglobin saturation curve
seen in chronic hemodialysis patients being responsible for an
increase in tissue oxygen extraction" which is negligible in
comparison with that seen during exercise.
Ureteral involvement in Wegener's granulomatosis. P. Ronco,
Y. Lanoe, J. Roland, L. Morel-Maroger, B. Gattegno, and F.
Mignon. Service de Néphrologie, Hôpital Tenon, Paris, France.
The occurrence of ureteral stenosis due to necrotizing angeitis is
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exceptional, although an early diagnosis may have important
therapeutic implications. In May, 1978, a 48-year-old man pre-
sented with a multisystemic disease with fever, peripheral neu-
ropathy, and glomerulonephritis. On a muscular biopsy exam,
the presence of necrotizing arteritis led to the diagnosis of poly-
arteritis nodosa. Steroids given during 6 months gave significant
clinical improvement. When they were discontinued in January
of 1979, the recurrence of fever and pulmonary symptoms led to
resuming steroids, together with anticoagulants. A few months
later, an IVP performed after a macroscopic hematuria showed a
right ureteral stenosis, which was cured surgically. Histologi-
cally, there was a granulomatous angeitis suggestive of a Wege-
ner's granulornatosis, and treatment with cyclophosphamide re-
sulted in a dramatic improvement of all symptoms. This observa-
tion shows that the diagnosis of necrotizing angeitis should be
considered in the etiology of ureteral stenosis. The mechanism
leading to ureteral obstruction probably combines edema and is-
chemia, due to angeitis affecting ureteral and periureteral arter-
ies. Early diagnosis is essential since Wegener's granulomatosis
is highly sensitive to cytostatic drugs.
Acquired factor XII (Hageman) deficiency associated with renal
amyloidosis. J. C. Sabatier, M. Croze, C. Genin, R. Gonthier,
and F. C. Berthoux. Service de Nephrologie, Hôpital de Belle-
vue, Saint Etienne, France. A young North African adult devel-
oped at age 22 a severe nephrotic syndrome (proteinuria = 25 g/
24 hr; total protein = 50 glliter and serum albumin = 14 g/liter)
with chronic renal failure (creatinine  1.5 mg/dl). A deficiency
in factor XII was discovered from a prolonged coagulation time
(23 mm), a prolonged cephalin-kaolin time (60 sec compared to
30 sec for control), and a very low level of functional factor XII
(activity at 5 and 12% of normal values) in the absence of pro-
coagulant activity. The existence of chronic rheumatism and
acute abdominal pain crisis in the relatives indicated the pres-
ence of familial mediterranean fever (FMF), confirmed by the
discovery of amyloidosis on the renal biopsy (no bleeding). The
study of the family (parents, 2 brothers, and 2 sisters) disclosed
no renal involvement, and factor XII level was in the normal
range. Our diagnosis was an acquired factor XII deficiency asso-
ciated with nephrotic syndrome and renal amyloldosis in a pa-
tient with FMF. The coagulation protein deficiencies described
up to now concerned factor X (Stuart) in association with renal
amyloidosis, and usually factor IX (antihemophilic B), and rarely
XI (plasma thromboplastin antecedent) in association with ne-
phrotic syndrome. At this point our case is unique. The patho-
genesis of this deficiency remains unclear: urinary loss of the
protein, favored by the parallel improvement of the deficiency
and the nephrotic syndrome in our case; in vivo hypercatabolism
of factor XII during activation process of kinins and fibrinolytic
systems; and fixation of the protein by the amyloid substance.
Recurrent vasculitis with hypocomplementemia and glomerulo-
nephritis: Two cases of MdftuflIe's syndrome. V. Saint-Hillier, R.
Laurent, M. Cassou, T. Dreyfus, H. Colomb, B. Hory, J. Pan-
ouse, G. Pageaut, G. Coulon, and C. Perol. Service de
Nephrologie, Médecine 5, CHU Saint-Jacques, France. In
1973, McDuffie et al reported four cases of vasculitis associated
with arthralgias, abdominal pain, low serum complement, and in
2 cases, with proliferative glomerulonephritis without laboratory
evidence of lupus or mixed cryoglobulinemia. Since then, similar
cases have been reported by Sisson, Soter, and Feig; one case
was reported in France by Alcalay et a! in 1978. We have ob-
served two cases. The first involved a 39-year-old woman, who
in 4 months had four recurrences of vasculitis, migrating arthral-
gias, transitory gross hematuria, renal insufficiency, and hypo-
complementemia. The low complement level and the renal in-
sufficiency disappeared after approximately I week. Renal
biopsy showed focal proliferative glomerulonephritis with elec-
tron-dense subendothelial deposits under electron microscopy;
no deposit was found by immunofluorescence. Skin biopsy
showed a leukocyte vasculitis as well as vascular deposits of
C'Iq, C'3, and fibrinogen by immunofluorescence. No relapse
was observed after steroid therapy was initiated. The second
case concerned a 33-year-old man who during a 3-year period
presented with recurrent purpura, arthralgias, abdominal pain,
diagnosed as Henoch-Schölein purpura. In our Unit, we ob-
served 10 relapses, each time associated with hypocomplemen-
temia, which returned to normal after several days. The com-
plement was activated through the classic pathway. The relapses
were increased by upright position and beer ingestion. Renal
biopsy showed focal segmental proliferative glomerulonephritis;
immunofluorescence revealed granular parietal deposits of IgG
and arteriolar deposits of C3. Moreover, deposits of C3 and fi-
bnnogen were found in the arterioles of the papillary dermis on
cutaneous biopsy. Serology tests were negative for hepatitis anti-
gen, antinuclear antibodies, and cryoglobulinemia. Since the pa-
tient has been on Dapsone therapy, no relapse of vasculitis has
been observed. Conclusion. (1) This type of vasculitis should be
considered as part of the differential diagnosis for patients pre-
senting recurrent macroscopic hematuria; (2) McDuffie's syn-
drome should be considered in nephritis with hypocomplemen-
temia.
Postpartum hemolytic uremic syndrome. Anne Segonds, Domi-
nique Durand, Claudine Orfila, and Jean-Michel Sac. Service de
Néphrologie et INSERM U 133, CHU Rangueil, Toulouse,
France. Three cases of postpartum hemolytic uremic syndrome
(HUS) are presented. Symptoms of acute renal failure, hyper-
tension, and microangiopathic hemolytic anemia with thrombo-
cytopenia occurred 10, 17, and 24 days after delivery. Despite
early heparin therapy in all the cases, one patient went into ter-
minal renal failure needing chronic hemodialysis, with persistent
hypertension which became uncontrollable requiring bilateral
nephrectomy 6 months later. The second patient had diuresis I
month after chronic hemodialysis, but 3 months later developed
malignant hypertension. Slight improvement in renal function
with persistent hypertension occurred after 20 months of hemo-
dialysis treatment. The third patient showed complete clinical
recovery after 2 months. Pathologic examination of renal tissue
showed lesions of thrombotic microangiopathy (TMA). How-
ever, striking differences were observed in the renal pathology
between early and late specimens. Early lesions could be dif-
ferentiated from infancy TMA because the medium size arteries
were more severely involved. Late lesions were variable, rang-
ing from minor changes in glomeruli and blood vessels, to is-
chemic and sclerotic lesions in glomeruli with arteriolosclerosis,
and to vascular and glomerular lesions seen in malignant nephro-
sclerosis. There was a good correlation between the renal pathol-
ogy and the clinical outcome. HUS with renal TMA as a cause of
postpartum renal failure has been reported in 49 patients, with a
fatal outcome in 61%. The pathogenesis of the syndrome prob-
ably involves primary endothelial damage causing a lack of pro-
stacyclin PGI2-synthesizing enzyme and thrombus formation en-
hanced by the constant postpartum hypercoagulability state.
Hypocomplementemia seen frequently as in two of our patients
is probably due to local and alternative pathway of C3 activation.
HLA A, B, and DR antigens in pre-eclampsia: Preliminary re-
sults. P. Simon, R. Fauchet, M. Menault, D. Bombail, B. Le
Fiblec, E. Panguy, J. Blanchard, and B. Cloup. Centre Hospi-
talier et Centre Departmental de Transfusion Sanguine, Saint-
Brieuc, Centre Regional de Transfusion Sanguine, Rennes,
France. HLA A, B and DR were studied in 26 women with pre-
eclampsia and in 16 of their husbands. Sixteen women with nor-
mal pregnancies and eleven of their husbands served as controls.
The severity of pre-eclampsia (HTA  28 weeks, nephrotic syn-
drome, eclampsia, early delivery, dysmaturity, perinatal death)
was compared with paternal/maternal histocompatibility. Prelim-
inary results indicate the following trends: (1) No particular HLA
A or B antigen was associated with pre-eclampsia but DRw4 an-
tigen was detected in 9/24 (37.5%) preeclamptic women com-
pared with 2/15 (13%) in control women. (2) HLA B (6/26) and
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HLA A and B (4/26) homozygosities were detected in pre-
eclampsia only, and for that reason histocompatibility was in-
creased in the preeclamptic couples. (3) There was a linear trend
of increasing histocompatibility with increasing severity of pre-
eclampsia. (4) DRw4 antigen was detected more often in pre-
eclamptic women with family history of hypertension (8/16) than
without (1/8).
Hemolysis and consumption coagulopathy due to overheated
dialysate. C. Tielemans, C.Herbaut, J. Geurts, and M. Dratwa.
Service de Médecine, Hôpital Universitaire Brugmann, Brus-
sels, Belgium. Despite the adoption of sophisticated alarm sys-
tems, hemodialysis (HD) remains a potentially hazardous proce-
dure. A 46-year-old woman with end-stage chronic glomerulo-
nephritis had been on thrice weekly HD for 4 months. Two hours
after beginning a routine HD, she complained of sudden pain at
her A-V fistula, without feeling warm. It was immediately noted
that, due to failure in both the thermostat and the alarm system,
the dialysate temperature was 52° C. HD was continued on an-
other machine without further problems. One hour after com-
pletion of HD, the patient complained of retrosternal and diffuse
abdominal pain, dyspnea, and nausea. Physical examination re-
vealed fever (38° C), chills, polypnea, jaundice and anemia, with
normal cardiopulmonar examination, blood pressure, and car-
diac rhythm. The A-V fistula was normal. On venous puncture,
she showed prolonged bleeding and during the first 24 hours
many routine measurements were impossible due to massive he-
molysis. The most representative results were: hemoglobin, 6.1
g/dl; white-cell count, 14,300; platelet count, 52,000; prothrom-
bin time, 21.5 sec.; fibrinogen, 136 mg/dl; fibrinogen degradation
products, between 640 and 1280 sg/ml; haptoglobin, 44 mg/dl;
bilirubin, 5.6 mg/dl; increased serum hemoglobin, methemalbu-
mm, SGPT and LDH, normal serum potassium and serum cop-
per concentrations. The Coombs Test was negative. Treatment
consisted in heparinization and infusion of fresh frozen plasma,
whole blood and packed red blood cells. Within 1 week, all labo-
ratory values had returned to their usual levels. Hemolysis has
been reported in four patients exposed to accidentally over-
heated dialysate. This fifth case was complicated by consump-
tion coagulopathy, which was probably due to the thromboplas-
tin-like activity of lysed erythrocytes or to the activation of clot-
ting through platelet or endothelial damage by heat.
Non-amyloid-related glomerular changes in two cases of light-
chain myeloma. R. Toulet, J. Gary, P. Le Pogamp, M. P.
Ramee, C. Esvant, and D. Chevet. Service de Néphrologie,
CHR, St. Brieuc, Unite Nephrologie-Reanima:ion Médicale,
CHU, Rennes, France. Two nondiabetic patients, 37 and 52
years old, having Kappa-chain myeloma with mild renal in-
sufficiency, were investigated. In both cases, renal biopsies
showed diffuse nodular glomerulosclerosis; in contrast, tubular
lesions were mild. Polychromatophil and fragmented protein
casts, syncitial cells were rare and conspicuous. There was no
evidence of amyloid deposits. Immunofluorescent studies
showed fixation of only specific anti-Kappa-chain on the gb-
merular nodular sites, and in one patient also on the tubular base-
ment membrane. These unusual immunopathologic features sug-
gest that: (1) clinical picture of glomerulopathy in light chain
myeloma is not strongly related to amyboid substance deposit, (2)
light chain toxicity" is not limited to the tubular cells, (3) in the
kidney, evidence for the M-component is not a constant patho-
logic feature in the similar previously reported cases. The nature
of nodular structure remains to be determined.
Correlations between renal function, renal arteriolar lesions,
blood pressure, and plasma renin activity after toxemia of preg-
nancy. P. Zech, N. Pozet, S. Colon, A. Gomes. Clinique de
Nephrologie, INSERM U 80, Hopital Ed. Herriot, Lyon,
France. Eighty-three women (26.6 5.6 years) were observed
after toxemia of pregnancy. Renal function was assessed by in-
ulin clearance (C1), PAH clearance (CPAH), filtered fraction (FF),
and plasma renin activity (PRA). Blood pressure (BP) was mea-
sured. Arteriolar lesions in kidney biopsies were determined. An
index of arteriolar disease (lAD) was defined by observation and
counting of arteriolar sections (endothelitis, media edema and
vacuolization, deposits). There was no modification in blood
pressure, clearances or arteriolar lesions between period 1(0 to 3
months) and IV (1 to 4 years) after the term of pregnancy. The
following correlations were found (P <0.05): 1) between BP and
CPAH decrease after 12 months, (2) between FF increase and per-
sistence of proteinuria, (3) between LAD and BP during periods I
and IV, (4) between lAD and C1 decrease, (5) between LAD and
PRA. Conclusions. The degree and chronic evolution of high
blood pressure 12 months after toxemia of pregnancy are statisti-
cally correlated with the arteriolar lesions, the decrease of renal
blood flow CPAH, and the increase in PRA.
